Orbimed Advisors LLC Onconova Therapeutics, Inc. Transaction History
Orbimed Advisors LLC
- $4.15 Billion
- Q2 2024
A detailed history of Orbimed Advisors LLC transactions in Onconova Therapeutics, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 1,045,261 shares of ONTX stock, worth $616,703. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,045,261Holding current value
$616,703% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ONTX
# of Institutions
30Shares Held
2.89MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA707KShares$417,0830.0% of portfolio
-
Black Rock Inc. New York, NY249KShares$146,8380.0% of portfolio
-
Geode Capital Management, LLC Boston, MA224KShares$132,2100.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny218KShares$128,6750.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il121KShares$71,3960.0% of portfolio
About Onconova Therapeutics, Inc.
- Ticker ONTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,895,600
- Market Cap $12.3M
- Description
- Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...